Skip to content
AwardedFranceServices€270,000

Etude intégrée d'un composé chimique à visée thérapeutique : de la synthèse à la caractérisation ADME/PK et à l'efficacité in vivo

Published
Published 19 December 2024
Deadline
Closed 20 January 2025

Overview

La présente consultation a pour objet de sélectionner un prestataire qui sera chargé de réaliser une étude intégrée d'un composé chimique à visée thérapeutique : de la synthèse à la caractérisation ADME/PK et à l'efficacité in vivo .

Key details

Country
France
Status
Awarded
Category
Services
Estimated value
€270,000
Procedure
Open
Published
19 December 2024
Deadline
Closed
Classification (CPV)
Research and experimental development services

Award outcome

Awarded value
€270,000
Award date
6 February 2025
Contract period
— → 1 February 2026
Winner
  • NOVALIX

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    17 April 2025

  2. Contract Notice

    19 December 2024

Contracting authority

  • SATT OUEST VALORISATION

    Procuring entity

    Rennes, France

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Etude intégrée d'un composé chimique à visée thérapeutique : de la synthèse à la caractérisation ADME/PK et à l'efficacité in vivo — won by NOVALIX — Skim